Screener
Phathom Pharmaceuticals, Inc. PHAT Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
FAQ
- What is Phathom Pharmaceuticals, Inc.'s free cash flow margin?
- Phathom Pharmaceuticals, Inc. (PHAT) reported free cash flow margin of -15.4% in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s free cash flow margin changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s free cash flow margin increased by 93.6% year-over-year, from -241% to -15.4%.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s free cash flow margin?
- Over 2 years (2023 to 2025), Phathom Pharmaceuticals, Inc.'s free cash flow margin has grown at a -93.2% compound annual growth rate (CAGR), from -20,412.6% to -95.4%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Phathom Pharmaceuticals, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude